Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 088290
Company: ABRAXIS PHARM
Company: ABRAXIS PHARM
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
NANDROLONE DECANOATE | NANDROLONE DECANOATE | 100MG/ML | INJECTABLE;INJECTION | Discontinued | None | No | No |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
02/04/1991 | SUPPL-12 | Labeling |
Label is not available on this site. |
||
03/17/1989 | SUPPL-7 | Labeling |
Label is not available on this site. |